Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously ...

Nanomedicine holds immense promise for revolutionizing healthcare. By manipulating materials at the nanoscale, researchers are developing innovative therapies and diagnostic tools that offer ...

一些Biotech 企业将目光投向 CDMO 赛道，试图通过延伸业务线缓解资金压力并盘活闲置产能。Biotech 入局 CDMO，究竟是踏上了通往风口的康庄大道 ...

The last decade has seen a considerable rise in CDMOs with an increasingly dynamic mergers and acquisition (M&A) landscape ...

An ideal CDMO partner demonstrates a comprehensive understanding of the regulatory landscape, backed by a strong track record of regulatory compliance. Case studies based on relevant successful ...

By investing in two technology platforms, the South Korea-based contract development and manufacturing organization (CDMO) has positioned itself to support external clients and its two biotech ...

and AI-driven process optimization is transforming the CMO/CDMO landscape. Regulatory Compliance and Quality Standards With stringent global regulatory requirements, pharmaceutical firms prefer ...

Companies operating in the pharmaceutical and biotech sectors must evaluate a range of critical factors prior to partnering with a contract development and manufacturing organization (CDMO).